Body

Are dietary supplements working against you?

Do you belong to the one-half of the population that frequently uses dietary supplements with the hope that it might be good for you?

Caltech: Learning to tolerate our microbial self

PASADENA, Calif.—The human gut is filled with 100 trillion symbiotic bacteria—ten times more microbial cells than our own cells—representing close to one thousand different species. "And yet, if you were to eat a piece of chicken with just a few Salmonella, your immune system would mount a potent inflammatory response," says Sarkis K. Mazmanian, assistant professor of biology at the California Institute of Technology (Caltech).

A new ending to an old 'tail'

LA JOLLA, CA—In stark contrast to normal cells, which only divide a finite number of times before they enter into a permanent state of growth arrest or simply die, cancer cells never cease to proliferate. Now, scientists at the Salk Institute for Biological Studies have uncovered an important clue to one of the mechanisms underlying cancer cell immortality.

Penn research using frog embryos leads to new understanding of cardiac development

PHILADELPHIA--During embryonic development, cells migrate to their eventual location in the adult body plan and begin to differentiate into specific cell types. Thanks to new research at the University of Pennsylvania, there is new insight into how these processes regulate tissues formation in the heart.

Over range of ADHD behavior, genes major force on reading achievement, environment on math

Humans are not born as blank slates for nature to write on. Neither are they behaving on genes alone.

Research by Lee A. Thompson, chair of Case Western Reserve University's Psychological Sciences Department, and colleagues found that the link between Attention-Deficit/Hyperactivity Disorder (ADHD) and academic performance involves a complex interaction of genes and environment.

Liver-cell transplants show promise in reversing genetic disease affecting liver and lungs

April 21, 2011 -- (Bronx, NY) -- Transplanting cells from healthy adult livers may work in treating a genetic liver-lung disorder that affects millions of people worldwide, according to an animal study in the April 18 online edition of the Journal of Clinical Investigation.

Signaling pathway reveals mechanism for B cell differentiation in immune response

An article in Science Signaling by researchers at the RIKEN Research Center for Allergy and Immunology (RCAI) has clarified for the first time the mechanism governing differentiation of B cells into antibody-producing plasma cells. The finding establishes a role for the extracellular signal-regulated kinase (ERK) signaling pathway in B cell differentiation, a key step toward the development of B cell-targeted drugs for treatment of autoimmune diseases and allergies.

TGen findings contribute to understanding of diabetic kidney disease

PHOENIX, Ariz.-- April 22, 2011-- A gene called PVT1 may help reduce the kidneys ability to filter blood, leading to kidney disease, kidney failure and death, according to a study published today by researchers at the Translational Genomics Research Institute (TGen).

The TGen team found PVT1 expression levels increased up to 5-fold in response to hyperglycemia, or high blood sugar, a condition that often accompanies diabetes.

IADR/AADR Journal of Dental Research releases studies on oral health inequalities in older people

Alexandria, Va., USA – The International and American Associations for Dental Research (IADR/AADR) have published two studies about oral health inequalities in older people and low income individuals. These articles, titled "Income-related Inequalities in Dental Service Utilization by Europeans Aged 50+" by Stefan Listl, and "Income Inequality and Tooth Loss in the United States" by Eduardo Bernabe and Wagner Marcenes, are published in the Journal of Dental Research, the official publication of the IADR/AADR.

Scotland's first marine reserve already producing benefits

Scotland's first fully protected marine reserve, and only the second in the UK, is already providing commercial and conservation benefits, according to new research.

After only two years in operation, it is already showing positive signs for both fishermen and conservationists, according to a study by the University of York and the Community of Arran Seabed Trust (COAST).

New approach to defeating flu shows promise

New research on mice has shown that pulmonary administration of granulocyte macrophage-colony stimulating factor (GM-CSF) significantly reduces flu symptoms and prevents death after a lethal dose influenza virus. While GM-SCF therapy for humans as a flu prophylaxis or treatment may be years away, the study results were striking: All of the mice treated with GM-SCF survived after being infected with the influenza virus, whereas untreated mice all died from the same infection.

Drug effective in treating kidney disease in diabetic patients

Researchers at the University of California, San Diego School of Medicine, the National Institutes of Health (NIH) and the Mayo Clinic have published promising results of a clinical study using an experimental anti-fibrotic and anti-inflammatory drug called pirfenidone to treat patients with diabetic nephropathy. Their study will be published in the April 21 issue of the Journal of the American Society of Nephrology (JASN).

Kidney disease coupled with heart disease common problem in elderly

Chronic kidney disease (CKD) is common and linked with heart disease in the very elderly, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

In time for spring, biologist illuminates how seedlings regulate growth

PROVIDENCE, R.I. [Brown University] — With seedlings and shoots still poking their leafy tops out of the soil, it's hard to read the newly published research of Brown University biologist Alison DeLong without musing that it provides a deeper understanding of what puts the spring in spring.

Researchers identify genes causing antimalarial drug resistance

Boston, MA -- Using a pair of powerful genome-search techniques, researchers from the Harvard School of Public Health (HSPH), Harvard University, and the Broad Institute have identified several genes that may be implicated in the malaria parasite's notorious ability to rapidly evade drug treatments. Further testing revealed that one of the genes, when inserted into drug-sensitive parasites, rendered them less vulnerable to three antimalarial drugs.